Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Minority Interest for 2 consecutive years, with $96.8 million as the latest value for Q2 2024.

  • Quarterly Minority Interest changed N/A to $96.8 million in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $96.8 million through Jun 2024, changed N/A year-over-year, with the annual reading at $96.8 million for FY2023, N/A changed from the prior year.
  • Minority Interest for Q2 2024 was $96.8 million at Artiva Biotherapeutics, roughly flat from $96.8 million in the prior quarter.
  • The five-year high for Minority Interest was $96.8 million in Q4 2023, with the low at $96.8 million in Q4 2023.